BeNeLuxA, the cross-country medicines access coalition is calling for a paradigm shift in pharmaceutical innovation from a supply driven system to a “more needs driven model.” The coalition has welcomed the European Commission’s proposals for reforming EU pharmaceutical legislation, but says more needs to be done to ensure patients get the medicines they require, for example by establishing an EU-level system for defining unmet need and using it to incentivize and reward innovation.
Key Takeaways
-
Pharmaceutical innovation should be guided by the needs of society and patients rather than by potential return on investment.
-
Member states should adopt an EU-wide approach to defining and grading unmet need to encourage development in priority areas
BeNeLuxA is an initiative made up of Belgium, the Netherlands, Luxembourg, Austria and Ireland that aims to improve access to expensive medicines
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?